Experts sound the alarm as chronic kidney disease is surging and ignoring these early symptoms could lead to dialysis or a ...

Two significant programs that invested in research on diabetes, dementia, obesity and kidney disease have ended since the ...

For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people ...

In March 2025, Shandong Suncadia Medicine Co., Ltd. conducted a phase II Clinical Study of Efficacy and Safety of HRS-1780 ...

Chronic Kidney Disease (CKD) affects approximately 15% of U.S. adults and as many as 9 in 10 with CKD are unaware they have ...

Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor ...

A research team has developed a compact peritoneal dialysis device that can be utilized as a portable artificial kidney. This ...

Kidney failure affects millions worldwide, and the number keeps rising. Each year, the global population of patients with end ...

In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...